← Evidence map

ArticleLeukemia2021

MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance.

Jordy C G van der Zwet et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

29 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 34007050